Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Invested Capital: 2010-2024

Historic Invested Capital for OptimizeRx (OPRX) over the last 15 years, with FY2024 value amounting to $151.3 million.

  • OptimizeRx's Invested Capital rose 2969.82% to $151.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.1 million, marking a year-over-year increase of 2969.82%. This contributed to the annual value of $151.3 million for FY2024, which is 822.3% down from last year.
  • According to the latest figures from FY2024, OptimizeRx's Invested Capital is $151.3 million, which was down 822.3% from $164.8 million recorded in FY2023.
  • Over the past 5 years, OptimizeRx's Invested Capital peaked at $164.8 million during FY2023, and registered a low of $50.3 million during FY2020.
  • In the last 5 years, OptimizeRx's Invested Capital had a median value of $131.4 million in 2021 and averaged $124.8 million.
  • As far as peak fluctuations go, OptimizeRx's Invested Capital soared by 16140.17% in 2021, and later plummeted by 822.3% in 2024.
  • Annual analysis of 5 years shows OptimizeRx's Invested Capital stood at $50.3 million in 2020, then surged by 161.4% to $131.4 million in 2021, then dropped by 4.01% to $126.1 million in 2022, then skyrocketed by 30.71% to $164.8 million in 2023, then dropped by 8.22% to $151.3 million in 2024.
  • Its Invested Capital stands at $151.3 million for FY2024, versus $164.8 million for FY2023 and $126.1 million for FY2022.